SlideShare a Scribd company logo
1 of 10
Download to read offline
Welcome
INSTITUTIONAL REVIEW BOARD OR INDEPENDENT
ETHICS COMMITTEE (IRB/IEC)
D. BHAVANI SHANKAR
PHARM D
Student ID: 155/0822
11/5/2022
www.clinosol.com | follow us on social media
@clinosolresearch
1
What is Institutional review board/ Independent
ethics committee (IRB/IEC)
➢IRB/IEC serves as an independent body that reviews, evaluates, approves and
decides on the scientific and ethical aspects of the clinical trail protocols well as the
benefits and risks to the study participants.
11/5/2022
www.clinosol.com | follow us on social media
@clinosolresearch
2
Purpose of IRB/IEC
11/5/2022
www.clinosol.com | follow us on social media
@clinosolresearch
3
Main purpose of IRB/IEC is to protect the rights, safety, and well-being
of the subjects who participate in a clinical trail.
Composition of IRB/IEC
➢Consists of individuals with the knowledge and experience necessary to
study and assess the science, medical implications, and ethical implications
of the planned trails.
➢Consists of a minimum of five participants, at least one of whom has a
primary interest outside of science and at least one of whom is not affiliated
with the university or trail site.
11/5/2022
www.clinosol.com | follow us on social media
@clinosolresearch
4
Members of IEC
➢Chair person
➢1-2 medical scientists
➢1-2 clinicians from various institutes
➢One legal expert or retired judge
➢One social scientist
➢One philosopher/ethicist
➢One lay man
➢Member secretary
11/5/2022
www.clinosol.com | follow us on social media
@clinosolresearch
5
Responsibilities of IRB/IEC
➢protect each trial subject's rights, safety, and wellbeing.
➢Reviews a proposed clinical trail with in a reasonable time and document its
views in writing.
➢performs regular reviews of each active trail at least once a year.
➢Give the researchers guidance on all matters pertaining to the welfare and
safety of research participants.
11/5/2022
www.clinosol.com | follow us on social media
@clinosolresearch
6
Responsibilities of IRB/IEC
➢Ensures that the written informed consent form and any other written
information are supplied to the subjects. This information on payment
to subjects (including the methods, amounts, and schedule of payment)
must be included.
11/5/2022
www.clinosol.com | follow us on social media
@clinosolresearch
7
Procedures of IRB/IEC
➢Determine its composition and authority under which it is established.
➢Schedules, informs the group's participants about, and runs its
meetings.
➢Beginning and ongoing trail reviews are done.
➢Clearly states that no subject should be allowed to enter a trail before
the IRB/IEC issues a written opinion of approval for the path.
➢Explains the details that the researcher must immediately provide to
the IRB/IEC (like deviations from the protocol, adverse drug reaction
etc.)
11/5/2022
www.clinosol.com | follow us on social media
@clinosolresearch
8
Maintenance of records of IRB/IEC
➢After the trial is finished, the IRB/IEC keeps all pertinent records
(such as written procedures, member lists by occupations and
affiliations, materials presented, meeting minutes, etc.) for at least
three years and makes them available to the regulatory authority upon
request.
➢IRB/IEC may be asked by investigators, sponsors, or regulatory
authorities to provide copies of its written procedures and membership
lists.
11/5/2022
www.clinosol.com | follow us on social media
@clinosolresearch
9
ThankYou!
www.clinosol.com
(India | Canada)
9121151622/623/624
info@clinosol.com
11/5/2022
www.clinosol.com | follow us on social media
@clinosolresearch
10

More Related Content

What's hot

Regulation of biosimilar in India
Regulation of biosimilar in India Regulation of biosimilar in India
Regulation of biosimilar in India Palesh Rajkondawar
 
Comparasion of IND,NDA,BLA,ANDA,OTC
Comparasion of IND,NDA,BLA,ANDA,OTCComparasion of IND,NDA,BLA,ANDA,OTC
Comparasion of IND,NDA,BLA,ANDA,OTCGuru Balaji .S
 
4. Unit-IV:- Clinical Trials.
4. Unit-IV:- Clinical Trials.4. Unit-IV:- Clinical Trials.
4. Unit-IV:- Clinical Trials.Audumbar Mali
 
Protocol development
Protocol developmentProtocol development
Protocol developmentAlisha Bansal
 
Regulation in clinical trial, Schedule Y and recent amendments
Regulation in clinical trial, Schedule Y and recent amendmentsRegulation in clinical trial, Schedule Y and recent amendments
Regulation in clinical trial, Schedule Y and recent amendmentsDr. Siddhartha Dutta
 
Pharmacovigilance safety Mon. in clinical trials.pptx
Pharmacovigilance safety Mon. in clinical trials.pptxPharmacovigilance safety Mon. in clinical trials.pptx
Pharmacovigilance safety Mon. in clinical trials.pptxRoshan Yadav
 
Ind (investigational new drug application) and nda
Ind (investigational new drug application) and ndaInd (investigational new drug application) and nda
Ind (investigational new drug application) and ndaswati2084
 
Global Subbmission of IND, NDA, ANDA
Global Subbmission of IND, NDA, ANDA Global Subbmission of IND, NDA, ANDA
Global Subbmission of IND, NDA, ANDA Maruthi.N
 
The New Drugs and Clinical Trials (Amendment) Rules, 2023.
The New Drugs and Clinical Trials (Amendment) Rules, 2023. The New Drugs and Clinical Trials (Amendment) Rules, 2023.
The New Drugs and Clinical Trials (Amendment) Rules, 2023. ClinosolIndia
 
clinical trial application in india
clinical trial application in indiaclinical trial application in india
clinical trial application in indiaRohit K.
 
INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)
INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)
INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)sagartrivedi14
 
Investigational New Drug Application
Investigational New Drug ApplicationInvestigational New Drug Application
Investigational New Drug ApplicationSuhas Reddy C
 
Investigational New drug application [INDA]
Investigational New drug application [INDA]Investigational New drug application [INDA]
Investigational New drug application [INDA]Sagar Savale
 
Clinical trial protocol development
Clinical trial protocol developmentClinical trial protocol development
Clinical trial protocol developmentSACHIN C P
 

What's hot (20)

Regulation of biosimilar in India
Regulation of biosimilar in India Regulation of biosimilar in India
Regulation of biosimilar in India
 
Drug master file
Drug master fileDrug master file
Drug master file
 
Comparasion of IND,NDA,BLA,ANDA,OTC
Comparasion of IND,NDA,BLA,ANDA,OTCComparasion of IND,NDA,BLA,ANDA,OTC
Comparasion of IND,NDA,BLA,ANDA,OTC
 
Schedule y
Schedule ySchedule y
Schedule y
 
Post approval of drugs
Post approval of drugsPost approval of drugs
Post approval of drugs
 
4. Unit-IV:- Clinical Trials.
4. Unit-IV:- Clinical Trials.4. Unit-IV:- Clinical Trials.
4. Unit-IV:- Clinical Trials.
 
Protocol development
Protocol developmentProtocol development
Protocol development
 
Regulation in clinical trial, Schedule Y and recent amendments
Regulation in clinical trial, Schedule Y and recent amendmentsRegulation in clinical trial, Schedule Y and recent amendments
Regulation in clinical trial, Schedule Y and recent amendments
 
Pharmacovigilance safety Mon. in clinical trials.pptx
Pharmacovigilance safety Mon. in clinical trials.pptxPharmacovigilance safety Mon. in clinical trials.pptx
Pharmacovigilance safety Mon. in clinical trials.pptx
 
Ind (investigational new drug application) and nda
Ind (investigational new drug application) and ndaInd (investigational new drug application) and nda
Ind (investigational new drug application) and nda
 
Global Subbmission of IND, NDA, ANDA
Global Subbmission of IND, NDA, ANDA Global Subbmission of IND, NDA, ANDA
Global Subbmission of IND, NDA, ANDA
 
The New Drugs and Clinical Trials (Amendment) Rules, 2023.
The New Drugs and Clinical Trials (Amendment) Rules, 2023. The New Drugs and Clinical Trials (Amendment) Rules, 2023.
The New Drugs and Clinical Trials (Amendment) Rules, 2023.
 
clinical trial application in india
clinical trial application in indiaclinical trial application in india
clinical trial application in india
 
Nda
NdaNda
Nda
 
Ich gcp
Ich gcpIch gcp
Ich gcp
 
Code of Federal Regulations
Code of Federal RegulationsCode of Federal Regulations
Code of Federal Regulations
 
INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)
INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)
INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)
 
Investigational New Drug Application
Investigational New Drug ApplicationInvestigational New Drug Application
Investigational New Drug Application
 
Investigational New drug application [INDA]
Investigational New drug application [INDA]Investigational New drug application [INDA]
Investigational New drug application [INDA]
 
Clinical trial protocol development
Clinical trial protocol developmentClinical trial protocol development
Clinical trial protocol development
 

Similar to Institutional review board or Independent ethics committee.pdf

Role of IRB and IEC in Safeguarding the Subjects in Clinical Trials
Role of IRB and IEC in Safeguarding the Subjects in Clinical TrialsRole of IRB and IEC in Safeguarding the Subjects in Clinical Trials
Role of IRB and IEC in Safeguarding the Subjects in Clinical TrialsClinosolIndia
 
An overview of Institutional Review Board or Independent Ethics Committee
An overview of Institutional Review Board or Independent Ethics CommitteeAn overview of Institutional Review Board or Independent Ethics Committee
An overview of Institutional Review Board or Independent Ethics CommitteeClinosolIndia
 
An overview of Institutional Review Board or Independent Ethics Committee
An overview of Institutional Review Board or Independent Ethics CommitteeAn overview of Institutional Review Board or Independent Ethics Committee
An overview of Institutional Review Board or Independent Ethics CommitteeClinosolIndia
 
Institutional ethics committee : Roles and Responsibilities
Institutional ethics committee : Roles and ResponsibilitiesInstitutional ethics committee : Roles and Responsibilities
Institutional ethics committee : Roles and ResponsibilitiesDrSahilKumar
 
Addressing ethics in clinical research
Addressing ethics in clinical research Addressing ethics in clinical research
Addressing ethics in clinical research Dr.MK Sudashan
 
Institutional ethics committee & informed consent
Institutional ethics committee & informed consentInstitutional ethics committee & informed consent
Institutional ethics committee & informed consentGaurav Yadav
 
IRB Review and Aproval Process and ongoing mointoring of safety data.pptx
IRB Review and Aproval Process and ongoing mointoring of safety data.pptxIRB Review and Aproval Process and ongoing mointoring of safety data.pptx
IRB Review and Aproval Process and ongoing mointoring of safety data.pptxAartiVats5
 
IBR, ICMR, Ethical Issues & Sch. Y
IBR, ICMR, Ethical Issues & Sch. YIBR, ICMR, Ethical Issues & Sch. Y
IBR, ICMR, Ethical Issues & Sch. YDhruvi50
 
Organization of IRBs and SOPs.pptx
Organization of IRBs and SOPs.pptxOrganization of IRBs and SOPs.pptx
Organization of IRBs and SOPs.pptxMelkamAndargie
 
Declaration of Helsinki
Declaration of HelsinkiDeclaration of Helsinki
Declaration of HelsinkiClinosolIndia
 
Protocol Writing in Clinical Research
Protocol Writing in Clinical ResearchProtocol Writing in Clinical Research
Protocol Writing in Clinical ResearchClinosolIndia
 
Good clinical practice (GCP)
Good clinical practice (GCP)Good clinical practice (GCP)
Good clinical practice (GCP)Ravish Yadav
 
INDIAN GCP GUIDELINE. for Regulatory affair 1st sem CRR
INDIAN GCP GUIDELINE. for Regulatory  affair 1st sem CRRINDIAN GCP GUIDELINE. for Regulatory  affair 1st sem CRR
INDIAN GCP GUIDELINE. for Regulatory affair 1st sem CRRsarwankumar4524
 
institutional ethics committee
institutional ethics committeeinstitutional ethics committee
institutional ethics committeeSirisha Annavarapu
 
Institutional ethics committee.pptx
Institutional ethics committee.pptxInstitutional ethics committee.pptx
Institutional ethics committee.pptxumarfarooque63
 
clinical trial start up activities lahar ppt 3.pptx
clinical trial start up activities lahar ppt 3.pptxclinical trial start up activities lahar ppt 3.pptx
clinical trial start up activities lahar ppt 3.pptxLahar Sambana
 
Research Governance Lecture
Research  Governance LectureResearch  Governance Lecture
Research Governance Lecturedrmomusa
 

Similar to Institutional review board or Independent ethics committee.pdf (20)

Role of IRB and IEC in Safeguarding the Subjects in Clinical Trials
Role of IRB and IEC in Safeguarding the Subjects in Clinical TrialsRole of IRB and IEC in Safeguarding the Subjects in Clinical Trials
Role of IRB and IEC in Safeguarding the Subjects in Clinical Trials
 
An overview of Institutional Review Board or Independent Ethics Committee
An overview of Institutional Review Board or Independent Ethics CommitteeAn overview of Institutional Review Board or Independent Ethics Committee
An overview of Institutional Review Board or Independent Ethics Committee
 
An overview of Institutional Review Board or Independent Ethics Committee
An overview of Institutional Review Board or Independent Ethics CommitteeAn overview of Institutional Review Board or Independent Ethics Committee
An overview of Institutional Review Board or Independent Ethics Committee
 
Institutional ethics committee : Roles and Responsibilities
Institutional ethics committee : Roles and ResponsibilitiesInstitutional ethics committee : Roles and Responsibilities
Institutional ethics committee : Roles and Responsibilities
 
Addressing ethics in clinical research
Addressing ethics in clinical research Addressing ethics in clinical research
Addressing ethics in clinical research
 
Institutional ethics committee & informed consent
Institutional ethics committee & informed consentInstitutional ethics committee & informed consent
Institutional ethics committee & informed consent
 
IRB Review and Aproval Process and ongoing mointoring of safety data.pptx
IRB Review and Aproval Process and ongoing mointoring of safety data.pptxIRB Review and Aproval Process and ongoing mointoring of safety data.pptx
IRB Review and Aproval Process and ongoing mointoring of safety data.pptx
 
IBR, ICMR, Ethical Issues & Sch. Y
IBR, ICMR, Ethical Issues & Sch. YIBR, ICMR, Ethical Issues & Sch. Y
IBR, ICMR, Ethical Issues & Sch. Y
 
Organization of IRBs and SOPs.pptx
Organization of IRBs and SOPs.pptxOrganization of IRBs and SOPs.pptx
Organization of IRBs and SOPs.pptx
 
Declaration of Helsinki
Declaration of HelsinkiDeclaration of Helsinki
Declaration of Helsinki
 
Protocol Writing in Clinical Research
Protocol Writing in Clinical ResearchProtocol Writing in Clinical Research
Protocol Writing in Clinical Research
 
IRB (1).pptx
IRB (1).pptxIRB (1).pptx
IRB (1).pptx
 
Good clinical practice (GCP)
Good clinical practice (GCP)Good clinical practice (GCP)
Good clinical practice (GCP)
 
ICH- GCP
ICH- GCPICH- GCP
ICH- GCP
 
INDIAN GCP GUIDELINE. for Regulatory affair 1st sem CRR
INDIAN GCP GUIDELINE. for Regulatory  affair 1st sem CRRINDIAN GCP GUIDELINE. for Regulatory  affair 1st sem CRR
INDIAN GCP GUIDELINE. for Regulatory affair 1st sem CRR
 
institutional ethics committee
institutional ethics committeeinstitutional ethics committee
institutional ethics committee
 
IRB (1).pdf
IRB (1).pdfIRB (1).pdf
IRB (1).pdf
 
Institutional ethics committee.pptx
Institutional ethics committee.pptxInstitutional ethics committee.pptx
Institutional ethics committee.pptx
 
clinical trial start up activities lahar ppt 3.pptx
clinical trial start up activities lahar ppt 3.pptxclinical trial start up activities lahar ppt 3.pptx
clinical trial start up activities lahar ppt 3.pptx
 
Research Governance Lecture
Research  Governance LectureResearch  Governance Lecture
Research Governance Lecture
 

More from dabloosaha

signaldetectionandmanagement-210803014643.pdf
signaldetectionandmanagement-210803014643.pdfsignaldetectionandmanagement-210803014643.pdf
signaldetectionandmanagement-210803014643.pdfdabloosaha
 
lecture05_causality-methods_2018_lareb_who-6-kl.pptx
lecture05_causality-methods_2018_lareb_who-6-kl.pptxlecture05_causality-methods_2018_lareb_who-6-kl.pptx
lecture05_causality-methods_2018_lareb_who-6-kl.pptxdabloosaha
 
guidelines-150703103126-lva1-app6891.pdf
guidelines-150703103126-lva1-app6891.pdfguidelines-150703103126-lva1-app6891.pdf
guidelines-150703103126-lva1-app6891.pdfdabloosaha
 
6-clinicaltrialsflowprocess-140512151315-phpapp02.pdf
6-clinicaltrialsflowprocess-140512151315-phpapp02.pdf6-clinicaltrialsflowprocess-140512151315-phpapp02.pdf
6-clinicaltrialsflowprocess-140512151315-phpapp02.pdfdabloosaha
 
pv-signalandsignaldetection-210915063241.pdf
pv-signalandsignaldetection-210915063241.pdfpv-signalandsignaldetection-210915063241.pdf
pv-signalandsignaldetection-210915063241.pdfdabloosaha
 
pharmacovigilance-111031093044-phpapp01.pdf
pharmacovigilance-111031093044-phpapp01.pdfpharmacovigilance-111031093044-phpapp01.pdf
pharmacovigilance-111031093044-phpapp01.pdfdabloosaha
 
aggregatereportingpvkatalysthls-170327013344.pdf
aggregatereportingpvkatalysthls-170327013344.pdfaggregatereportingpvkatalysthls-170327013344.pdf
aggregatereportingpvkatalysthls-170327013344.pdfdabloosaha
 
icsrnarrativewritingkatalysthls-170224043430.pdf
icsrnarrativewritingkatalysthls-170224043430.pdficsrnarrativewritingkatalysthls-170224043430.pdf
icsrnarrativewritingkatalysthls-170224043430.pdfdabloosaha
 
STUDY DESIGNS IN CLINICAL TRIALS.pdf
STUDY DESIGNS IN CLINICAL TRIALS.pdfSTUDY DESIGNS IN CLINICAL TRIALS.pdf
STUDY DESIGNS IN CLINICAL TRIALS.pdfdabloosaha
 

More from dabloosaha (9)

signaldetectionandmanagement-210803014643.pdf
signaldetectionandmanagement-210803014643.pdfsignaldetectionandmanagement-210803014643.pdf
signaldetectionandmanagement-210803014643.pdf
 
lecture05_causality-methods_2018_lareb_who-6-kl.pptx
lecture05_causality-methods_2018_lareb_who-6-kl.pptxlecture05_causality-methods_2018_lareb_who-6-kl.pptx
lecture05_causality-methods_2018_lareb_who-6-kl.pptx
 
guidelines-150703103126-lva1-app6891.pdf
guidelines-150703103126-lva1-app6891.pdfguidelines-150703103126-lva1-app6891.pdf
guidelines-150703103126-lva1-app6891.pdf
 
6-clinicaltrialsflowprocess-140512151315-phpapp02.pdf
6-clinicaltrialsflowprocess-140512151315-phpapp02.pdf6-clinicaltrialsflowprocess-140512151315-phpapp02.pdf
6-clinicaltrialsflowprocess-140512151315-phpapp02.pdf
 
pv-signalandsignaldetection-210915063241.pdf
pv-signalandsignaldetection-210915063241.pdfpv-signalandsignaldetection-210915063241.pdf
pv-signalandsignaldetection-210915063241.pdf
 
pharmacovigilance-111031093044-phpapp01.pdf
pharmacovigilance-111031093044-phpapp01.pdfpharmacovigilance-111031093044-phpapp01.pdf
pharmacovigilance-111031093044-phpapp01.pdf
 
aggregatereportingpvkatalysthls-170327013344.pdf
aggregatereportingpvkatalysthls-170327013344.pdfaggregatereportingpvkatalysthls-170327013344.pdf
aggregatereportingpvkatalysthls-170327013344.pdf
 
icsrnarrativewritingkatalysthls-170224043430.pdf
icsrnarrativewritingkatalysthls-170224043430.pdficsrnarrativewritingkatalysthls-170224043430.pdf
icsrnarrativewritingkatalysthls-170224043430.pdf
 
STUDY DESIGNS IN CLINICAL TRIALS.pdf
STUDY DESIGNS IN CLINICAL TRIALS.pdfSTUDY DESIGNS IN CLINICAL TRIALS.pdf
STUDY DESIGNS IN CLINICAL TRIALS.pdf
 

Recently uploaded

POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
MENTAL STATUS EXAMINATION format.docx
MENTAL     STATUS EXAMINATION format.docxMENTAL     STATUS EXAMINATION format.docx
MENTAL STATUS EXAMINATION format.docxPoojaSen20
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Celine George
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsKarinaGenton
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3JemimahLaneBuaron
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesFatimaKhan178732
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991RKavithamani
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxRoyAbrique
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfchloefrazer622
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsanshu789521
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application ) Sakshi Ghasle
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Sapana Sha
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 

Recently uploaded (20)

POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
MENTAL STATUS EXAMINATION format.docx
MENTAL     STATUS EXAMINATION format.docxMENTAL     STATUS EXAMINATION format.docx
MENTAL STATUS EXAMINATION format.docx
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its Characteristics
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and Actinides
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdf
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha elections
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application )
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 

Institutional review board or Independent ethics committee.pdf

  • 1. Welcome INSTITUTIONAL REVIEW BOARD OR INDEPENDENT ETHICS COMMITTEE (IRB/IEC) D. BHAVANI SHANKAR PHARM D Student ID: 155/0822 11/5/2022 www.clinosol.com | follow us on social media @clinosolresearch 1
  • 2. What is Institutional review board/ Independent ethics committee (IRB/IEC) ➢IRB/IEC serves as an independent body that reviews, evaluates, approves and decides on the scientific and ethical aspects of the clinical trail protocols well as the benefits and risks to the study participants. 11/5/2022 www.clinosol.com | follow us on social media @clinosolresearch 2
  • 3. Purpose of IRB/IEC 11/5/2022 www.clinosol.com | follow us on social media @clinosolresearch 3 Main purpose of IRB/IEC is to protect the rights, safety, and well-being of the subjects who participate in a clinical trail.
  • 4. Composition of IRB/IEC ➢Consists of individuals with the knowledge and experience necessary to study and assess the science, medical implications, and ethical implications of the planned trails. ➢Consists of a minimum of five participants, at least one of whom has a primary interest outside of science and at least one of whom is not affiliated with the university or trail site. 11/5/2022 www.clinosol.com | follow us on social media @clinosolresearch 4
  • 5. Members of IEC ➢Chair person ➢1-2 medical scientists ➢1-2 clinicians from various institutes ➢One legal expert or retired judge ➢One social scientist ➢One philosopher/ethicist ➢One lay man ➢Member secretary 11/5/2022 www.clinosol.com | follow us on social media @clinosolresearch 5
  • 6. Responsibilities of IRB/IEC ➢protect each trial subject's rights, safety, and wellbeing. ➢Reviews a proposed clinical trail with in a reasonable time and document its views in writing. ➢performs regular reviews of each active trail at least once a year. ➢Give the researchers guidance on all matters pertaining to the welfare and safety of research participants. 11/5/2022 www.clinosol.com | follow us on social media @clinosolresearch 6
  • 7. Responsibilities of IRB/IEC ➢Ensures that the written informed consent form and any other written information are supplied to the subjects. This information on payment to subjects (including the methods, amounts, and schedule of payment) must be included. 11/5/2022 www.clinosol.com | follow us on social media @clinosolresearch 7
  • 8. Procedures of IRB/IEC ➢Determine its composition and authority under which it is established. ➢Schedules, informs the group's participants about, and runs its meetings. ➢Beginning and ongoing trail reviews are done. ➢Clearly states that no subject should be allowed to enter a trail before the IRB/IEC issues a written opinion of approval for the path. ➢Explains the details that the researcher must immediately provide to the IRB/IEC (like deviations from the protocol, adverse drug reaction etc.) 11/5/2022 www.clinosol.com | follow us on social media @clinosolresearch 8
  • 9. Maintenance of records of IRB/IEC ➢After the trial is finished, the IRB/IEC keeps all pertinent records (such as written procedures, member lists by occupations and affiliations, materials presented, meeting minutes, etc.) for at least three years and makes them available to the regulatory authority upon request. ➢IRB/IEC may be asked by investigators, sponsors, or regulatory authorities to provide copies of its written procedures and membership lists. 11/5/2022 www.clinosol.com | follow us on social media @clinosolresearch 9